Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, ...

From "cumulative" health risks in men to the lack of residency training, Dr. Michael Christopher breaks down why dedicated skin checks are a necessity.

Oregon State University researchers have developed a new nanoparticle-based photothermal therapy that uses a low-power laser ...

Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, ...

Decreases in circulating tumor DNA (ctDNA) within the first month of immune checkpoint inhibitor (ICI) therapy were strongly ...

71 percent of patients had pathological complete response; 7 percent experienced grade 3 treatment-related adverse events.

A near-infrared light beam appears harmless, as it is a low-frequency type of light that does not have a dramatic effect but ...

Glenn Polyak thought he was out of options when his Stage 4 melanoma spread to his brain, until he became only the second ...

A newly identified driver of melanoma growth not only promotes tumor blood supply but also helps tumors evade immune attack.

Anti–PD-1 therapy (pembrolizumab, nivolumab) supports neoadjuvant and adjuvant management of higher-risk melanoma, offering durable remissions with less systemic toxicity than traditional chemotherapy ...

The FDA approved Scancell's phase 3 trial of iSCIB1+ for advanced melanoma, focusing on progression-free survival as a surrogate endpoint. Phase 2 SCOPE study showed 74% progression-free survival at ...

Breakthrough personalized mRNA vaccine cuts melanoma recurrence risk by 50% when combined with Keytruda, Moderna CEO reveals promising five-year results.